MicroRNAs (miRNAs) are small non-coding RNAs that are involved in different biological processes by suppressing target gene expression. Altered expression of miR-30a-5p has been reported in colon carcinoma. To elucidate its potential biological role in colon cancer, miR-30a-5p was overexpressed via a lentiviral vector system in two different colon cancer cell lines. This induced in both lines miR-30a-5p-mediated growth inhibition, attributable to a cell cycle arrest at the G 1 phase and an induction of apoptosis. Combining global gene expression analyses of miR-30a-5p transgenic line HCT116 with in silico miRNA target prediction, we identified the denticleless protein homolog (DTL) as a potential miRNA-30a-5p target. Subsequent reporter gene assays confirmed the predicted miR-30a-5p binding site in the 3#untranslated region of DTL. Importantly, overexpression of DTL in HCT116 cells partially rescued these cells from miR-30a-5p-mediated growth suppression. In addition, TP53 and CDKN1A expression were increased in miR-30a-5p-overexpressing HCT116 cells, suggesting that miR-30a-5p is able to modulate the cell cycle via a DTL-TP53-CDKN1A regulatory circuit. Finally, 379 colorectal cancer tissues were screened for DTL expression and DTL was found to be overexpressed in 95.8% of human colorectal cancers compared with normal colon mucosa. In conclusion, our data identified miR-30a-5p as a tumorsuppressing miRNA in colon cancer cells exerting its function via modulation of DTL expression, which is frequently overexpressed in colorectal cancer. Thus, our data suggest that restoring miR30a-5p function may prove useful as therapeutic strategy for tumors with reduced miR-30a-5p expression.
Introduction
MicroRNAs (miRNAs) are evolutionarily conserved, on average 22 nucleotides long non-coding RNAs capable of silencing gene expression at a post-transcriptional level via suppression of sequencecomplementary messenger RNA (mRNA) targets. This causes either degradation of mRNA or inhibition of translation, thus modulating expression of mRNA targets (1) . The number of verified human miRNAs is still expanding. The latest version of miRBase (release 17.0, April 2011) has annotated nearly 1500 miRNA sequences in the human genome. Bioinformatics and cloning studies suggest that each miRNA is able to control hundreds of target genes in humans. A recent report indicates that .60% of protein-encoding genes are under selective pressure to preserve pairing with miRNAs, indicating that miRNAs have the potential to regulate the majority of protein-encoding genes (2) . Therefore, it is not unexpected that miRNAs, since their discovery in the early 2000s, were found to be involved in diverse biological processes, including cell differentiation, proliferation and apoptosis (2) . A crucial role for miRNAs in tumor development has been firmly established by the identification of numerous miRNAs misregulated in any tumor type analyzed to date (3) . This applies also to colorectal carcinoma (CRC), which is among the leading cause of death worldwide (4, 5) . Although major progress has been made in the identification of miRNAs, which may play a role in colorectal cancer based on their expression pattern identified mostly via global miRNA expression analyses, experimental data revealing their function for colorectal cancer development is still for the majority of miRNAs very limited. To identify candidate miRNAs for functional analyses, we screened the published literature for dysregulated miRNAs in CRC consistently found at least in three studies, which were at the time of our search not yet functionally analyzed. Here, we focus on the functional analysis of miR-30a-5p, a member of the miR-30 family and which was reported to be downregulated in colorectal cancers (6) (7) (8) .
Reduced expression of miR-30a-5p was not only detected in CRC but also in non-small cell lung cancer and in thyroid anaplastic carcinoma in comparison with normal tissue (9, 10) and in chronic lymphocytic leukemia cells compared with normal CD5þ B cells (11) . Interestingly, miR30a-5p expression was identified to be protective for patients with gastric cancer (12) . Furthermore, downregulation of miR-30a-5p was described in embryonic stem cells versus differentiated cells (8) . Among the few experimentally confirmed target genes, snail homolog 1 (SNAI1) was identified in non-small cell lung cancer (10), whereas Martinez et al. (13) recently demonstrated a role for the miR-30 family in controlling cell cycle progression by interacting with v-myb myeloblastosis viral oncogene homolog (avian)-like 2 (MYBL2) oncogene in the HeLa cell line and in primary human foreskin fibroblasts. Lastly, miR-30a-5p was reported to be upregulated in cell lines derived from squamous cell carcinoma, in human head and neck and esophagus cancer, a finding which could not be validated in primary tissues from the same cancer types (14) .
Material and methods

Clinical specimens
Colorectal tissue samples from a total of 389 patients, comprising 10 adjacent normal mucosa and 379 primary colorectal adenocarcinomas [301 microsatellite stable (MSS) and 78 microsatellite instable (MSI)], were used for transcriptional profiling on HG_U133 plus 2.0 arrays. The 10 adjacent normal mucosa samples were collected from non-cancer areas located orally from the tumor. Tissue samples (median age 70 years) were collected between 1984 and 2005 and comprised 160 females and 212 males; seven samples were not annotated. Two hundred and eighty-nine samples were from the colon, 90 from the rectum and samples comprised 54 Dukes' stage A, 283 B, 31 C and 11 D with histologically confirmed metastases in distant organs. Further details, such as sample preparation and microarray profiling have been described previously (15, 16) . Informed consent was obtained from all patients according to local ethical regulations, and all studies were approved by local ethical committees according to the Helsinki Declaration.
Fresh frozen colon cancer tissues for microdissection and miR-30a expression analysis were collected from 10 patients, comprising 8 primary colorectal adenocarcinomas and 2 adjacent normal mucosa from non-cancer areas located orally from the tumor. Microdissection (J.M.) and RNA isolation has been described previously (17) . Informed consent was obtained from all patients according to local ethical regulations. The tissue collection was performed according to a protocol approved by the ethics committee of the Ruhr-University Bochum (permission no. 3841-10). Eagle's medium supplemented with 10% fetal calf serum, 100 U/ml penicillin and 100 lg/ml streptomycin (Invitrogen-Gibco, Karlsruhe, Germany). Cells were maintained in a humidified incubator with 10% CO 2 at 37°C. All cell lines were confirmed negative for mycoplasma by routine testing.
Cells
Vectors pLKO.1-puro-miR-30a-5p vector. The pLKO.1-puro-miR-30a-5p vector was constructed by annealing the sense 5#-ccggcttccagtcgaggatgtttacactcgagtgtaaacatcctcgactggaagtttttg-3# and antisense: 5#-aattcaaaaacttccagtcgaggatgtttacactcgagtgtaaacatcctcgactggaag-3# oligonucleotides to each other and subsequent cloning of the resulting double-stranded DNA molecule into the AgeI/EcoRI site of the pLKO.1-puro vector (kindly provided by Sheila Stewart) (15) . The sequence of the mature miR-30a-5p is underlined. The empty pLKO.1-puro vector was used as control.
Sponge vectors. Oligonucleotides containing two sequence regions spaced by four nucleotides either 100% complementary to the anti-guide sequence of miR-30a-5p [herein called antisense (as)-miR-30a-5p; of note our miR-30a-5p hairpin sequence doesn't contain the natural miR-30a-3p sequence rather than the 100% complementary sequence to miR-30a-5p], sponge against miR-30a-5p and a scramble sequence were synthesized (as-miR-30a-5p, miR-30a-5p and scramble sequences are italicised):
As-miR-30a-5p sponge: sense 5#-ctagatgtaaacatcctcgactggaagcgattgtaaacatcctcgactggaag-ggtac-3#, antisense 5#-ccttccagtcgaggatgtttacaatcgcttccagtcgaggatgtttacat-3#; miR-30a-5p sponge: sense 5#-ctagacttccagtcgagg atgtttacacgatcttccagtcgaggatgtttacaggtac-3#, antisense 5#-ctgtaaacatcctcgactggaagatcgtgtaaacatcctcgactggaagt-3#; Scramble sponge: sense 5#-ctagaggagctccaccgcggtggcatcgatggagctccaccgcggtggcatggtac-3#, antisense 5#-catg ccaccgcggtggagctccatcgatgccaccgcggtggagctcct-3#, annealed to each other and ligated into the XbaI and KpnI restriction sites within the 3#untranslated region (3#UTR) of the d4GFP gene cassette from the pSFFV-pd4egfp vector, containing a destabilized Green Fluorescent Protein (GFP) variant (kind gift from Luigi Naldini) (18) . The sponge sequence was controlled not to be able to trap any miRNAs other than as-miR-30a-5p using the 'RNA22 microRNA target detection' tool available online (http://cbcsrv.watson.ibm.com/ rna22.html).
pBabe-puro-flag-DTL. The flag-tagged coding region of denticleless protein homolog (DTL) was PCR-amplified from the pMSCV-puro-CDT2 vector kindly provided by A.Dutta (19) . The resulting PCR products were inserted into the BamHI and SalI sites of the retroviral vector pBabe-puro.
Virus production and viral infection
Lentiviruses were produced by transfecting packaging cells (human embryonic kidney 293T) with a 3-plasmid system. For transfections, helper plasmids pCMVDR8.2 and pHIT G were used. For retroviral virus particle generation, the packaging pHIT60 and the envelope pHIT G plasmids were cotransfected together with the pBabe-puro-flag-DTL retroviral vector. Details are described in the Supplementary material, available at Carcinogenesis Online.
Real-time cell analysis
Real-time cell analysis (RTCA) was performed using 16-well E-plates on the Dual Plate xCELLigence instrument (Roche Applied Science, Indianapolis, IN) (20) . This system measures a dimensionless parameter called cell index, which evaluates the ionic environment at an electrode/solution interface and integrates information on cell number (21) . Five thousand cells were plated in each well of the 16-well plates in 200 ll of cell culture medium. After adding the cells to the wells, cells were allowed to settle for 30 min at room temperature before being inserted into the xCELLigence instrument in a humidified incubator at 37°C with 10% CO 2 . The cells were allowed to grow for 24 h before 170 ll of media were removed and the virus supernatants were added to the cells. Continuous impedance measurements were then monitored every 10 min over 150 h. All assays were performed in triplicate.
RNA isolation
Total RNA was isolated from cells using the standard acid guanidinium thiocyanate-phenolchloroform extraction procedure (22) . Details are described in the Supplementary material, available at Carcinogenesis Online. Total RNA concentrations were measured using a NanoDropÒ ND-1000 Fluorospectrometer (NanoDrop Technologies, Wilmington, DE).
Gene expression analysis and data processing RNAs isolated from three parallel experiments for each vector construct combination were subjected to gene expression analyses using whole genome expression microarrays (Human GE 4x44K, v2 G4845A, AMADID 026652; Agilent Technologies, Santa Clara, CA). The gene expression data from our study have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (GEO) database (accession number GSE29921, accession for review purposes: http://www.ncbi.nlm.nih.gov/geo/ query/acc.cgi?token5nzqlfwecywcswve&acc5GSE29921). Following array data processing, differentially expressed genes were identified via the GeneSpring GX software package. Details are described in the Supplementary material, available at Carcinogenesis Online.
Quantitative real-time PCR For confirmation of selected genes identified in our microarray analyses [DTL, CDKN1A and cyclin-dependent kinase 1 (CDK1)], standard SYBR green-based quantitative real-time PCR (qRT-PCR) analyses were performed. Specific primer sequences were: DTL, forward primer 5#-aggcaaagagaatagttccccag-3# and reverse primer 5#-cggacttcgtggagatgga-3#; CDKN1A, forward primer 5#-ctggctcttgatacccccct-3# and reverse primer 5#-tcaacactgagacgggctcc-3#; CDK1, forward primer 5#-ggaaaccaggaagcctagca-3# and reverse primer 5#-tgattcagtgccattttgcc-3#. PCR cycling conditions were composed of an initial step at 94°C for 3 min followed by 40 cycles of 94°C for 30 s, 60°C for 30 s, 72°C for 30 s and a step of 82°C for 5 s. Fluorescence was measured at the last step of each cycle. The housekeeping genes UBC and PPIA were used to normalize the expression data for the gene of interest. Details are described in the Supplementary material, available at Carcinogenesis Online.
Luciferase reporter assay
To test the binding of miR-30a-5p to its predicted DTL target sequence, two segments of the human DTL 3#UTR (nt795-816 and nt1594-1615; National Center for Biotechnology Information reference sequence NM_016448.2), containing the predicted miR-30a-5p binding sites, were amplified by PCR using human genomic DNA as template. PCR primer sequences were: 5#-cgctcgagagctgagctttggtccacta-3# and 5#-tatctctagaatgactgcacctgaattcaa-3# for the segment nt795-816; 5#-cgctcgagcagagagtgtatagactgac-3# and 5#-tatctctagacaggcagggataattatctc-3# for the segment nt1594-1615. PCR products were inserted into the pCMV-GLuc vector downstream of the stop codon of Gaussia luciferase (New England Biolabs). In addition, the two miR-30a-5p binding sequences cloned into pCMV-Gluc were mutagenized via the Stratagene QuikChange II Site-Directed Mutagenesis Kit (Agilent Technologies), rendering the pGLuc-DTL-3'UTR-mut795-816 and pGLuc-DTL-3'UTR-mut1594-1615 constructs. A vector expressing ß-galactasidase served as a control to monitor transfection efficiency. Each reporter analysis was controlled by an independent second experiment. Further details are described in the Supplementary material, available at Carcinogenesis Online.
Cell cycle analysis and apoptosis detection by flow cytometry
The cell preparation and staining for cell cycle analyses are described in detail in the Supplementary data, available at Carcinogenesis Online. Apoptosis was quantified with Annexin-V Allophycocyanin (APC) (Becton Dickinson) in the presence of fluorescent tetramethylrhodamine ethyl ester (TMRE) (Enzo Life Sciences, Farmingdale, NY), which indicates changes in the mitochondrial membrane potential as a typical feature of apoptotic cells. The details about cell preparation and staining are described in the Supplementary data, available at Carcinogenesis Online.
Western blot analysis
For the protein expression analyses, standard western blottings were carried out. The following antibodies were used: rabbit anti-FLAG antibody (1:500; Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-DTL polyclonal antibody (1:200; BETHYL, Montgomery), mouse anti-p53 antibody (1:1000, DO-1; Santa Cruz Biotechnology), mouse anti-p21 antibody (1:100, F-5; Santa Cruz Biotechnology) and mouse anti-ß-tubulin antibody (1:750; Sigma-Aldrich, Taufkirchen, Germany). The details about the cell preparation are described in the Supplementary data, available at Carcinogenesis Online.
Statistical analysis
Statistical analysis was done using GraphPad Prism IV software. P values were calculated by two-sided Student's t-test. P values ,0.05 were considered significant, values ,0.01 were considered highly significant. Mean ± SD is displayed in the figures.
Results
MiR-30a-5p inhibits cell growth of different colon cancer cell lines MiR-30a-5p overexpression was achieved in colon carcinoma cell lines via a lentiviral vector system. In order to control for potential differences in the response toward miR-30a-5p overexpression between the two major CRC progression models, (i) following the standard tumor progression model and being MSS or (ii) the hereditary non-polyposis colorectal cancer progression model driven by mismatch repair deficiency (also rendering these cells MSI), we choose two cell lines as representatives for each condition (SW480 and MSS MiR-30a-5p targets DTL in colon carcinoma and HCT116 and MSI). Endogenous miR-30a-5p expression levels were measured in both lines via qRT-PCR (Supplementary Table SI is available at Carcinogenesis Online). In the first round of miR-30a-5p overexpression experiments, we observed that transduction with miR30a-5p led to a pronounced reduction of in vitro cell counts of the HCT116 and SW480 cells. Ninety-six hours after miR-30a-5p overexpression, no viable cells were any more detectable in the tissue culture dish. To validate this observation more objectively, we subsequently analyzed the ability of miR-30a-5p to impede cell proliferation and/or reduce survival using RTCA. In Figure 1A , the substantial decrease of cell indices following transduction of HCT116 and SW480 cells with the pLKO.1-puro-miR-30a-5p vector (herein called miR-30a-5p) is shown. The successful expression of miR-30a-5p was quantified in a parallel experiment by qRT-PCR (Supplementary Table SI is available at Carcinogenesis Online). The expression of a miR-30a-5p sponge vector to suppress in HCT116 cells the already low endogenous miR-30a-5p expression level had no influence on cell growth (Supplementary Figure S7 is available at Carcinogenesis Online).
It has been shown previously that both strands of a small interfering RNA duplex or a short hairpin RNA can direct RNA interference (23) . To control for the possibility that transfection with our vector systems resulted in the production of two RNA-induced silencing complexes (RISCs), one derived from the guide and the other one from the antiguide strand, we transfected HCT116 and SW480 with a vector expressing a perfect binding site for the anti-guide strand of our miR30a-5p hairpin sequence (pSFFV-pd4egfp-as-30a-5p-sponge, herein called as-30a-5p-sponge) prior to the transfection of the cells with the miR-30a-5p expression vector. The efficient transduction of as-30a-5p-sponge vector and the production of a functional RISC from the Figure S1 is available at Carcinogenesis Online) using a GFP reporter system. Furthermore, changes in cell growth of cells transduced either with the miR-30a-5p and scr-sponge or with the miR-30a-5p and as30a-5p-sponge vector combination were again continuously registered via RTCA and grossly inspected in parallel in 10 cm tissue culture dishes. In line with previous reports (23), we found a significant left shift of the GFP signal distribution in our fluorescence-activated cell sorting analyses, indicating the production of RISCs containing the anti-guide sequence derived from our miR-30a-5p hairpin vector (Supplementary Figure S1 is available at Carcinogenesis Online). Furthermore, the fact that a significant proportion of our sponge sequenceexpressing cells are still GFP-positive was interpreted to the effect that in Figure S2 is available at Carcinogenesis Online). Again, all viable cells disappeared within 96 h in the parallel experiments using standard 10 cm cell culture dishes. We concluded from these observations that the guide strand of our miR-30a-5p hairpin vector is primarily responsible for the observed changes in cell growth.
In order to identify the potential mechanism responsible for the observed effects of miR-30a-5p on cell growth in colorectal cancer cells, we next evaluated apoptosis rates and cell cycle distribution in HCT116 and SW480 cells transduced with the miR-30a-5p vector. Apoptosis rates were evaluated via double staining of cells with TMRE and Annexin-V APC, distinguishing between apoptotic cells (positive for Annexin-V APC and negative for TMRE) and vital cells (negative for Annexin-VAPC and positive for TMRE). HCT116 cells transduced with control plasmid contained 1.4% of apoptotic cells. In contrast, cells transduced with miR-30a-5p yielded 12.5%, thus resulting in a significant increase of apoptotic cells ( Figure 1B) . Similar results were obtained for SW480 cells with 16.3% of apoptotic cells after transduction with miR-30a-5p compared with 3.2% in the control.
Cell cycle analyses of HCT116 cells following miR-30a-5p overexpression caused a G 1 arrest shown by an increased cell number in G 1 phase (52.9-73.36%) and a corresponding reduction of cells in the S phase (20.31-10.88%) and in particular a reduction in the G 2 /M populations (26.64-11.03%) ( Figure 1C ). Moreover, a prominent sub-G 1 apoptotic peak was detected after treatment with miR-30a-5p. MiR-30a-5p overexpression in SW480 cells led to similar results with an increased cell number in G 1 phase (53.56-77.14%) and a corresponding reduction in the G 2 /M populations (27.97-12.44%).
Microarray analysis for miRNA-30a-5p target identification
For the miR-30a-5p target gene identification, we assessed changes in the gene expression pattern of HCT116 cells under miR-30a-5p overexpression via whole genome gene expression profiling. For each of the two vector combinations (as-30a-5p-sponge and miR-30a-5p versus as-30a-5p-sponge and control vector), three parallel experiments were subjected to gene array analyses. The time-point for RNA isolation was 44 h post-transduction as determined by RTCA (see also the arrow in Supplementary Figure S2 is available at Carcinogenesis Online). Following data normalization and statistical analyses, we identified 343 genes showing a !1.5-fold change in expression upon miR-30a-5p vector transduction (Supplementary Table SII is available at Carcinogenesis Online). Comparing the 257 genes identified to be downregulated upon miR-30a-5p overexpression to the list of 5049 predicted target genes derived from in silico target prediction (miRanda; micro RNA.org, Release September 2008), we identified 23 common genes which were considered potential miR-30a-5p target genes (Supplementary Table SIII is available at Carcinogenesis Online). Based on our functional data of miR-30a-5p overexpression, showing G 1 arrest, we searched in our target candidate list for genes involved in cell cycle regulation using the Gene Ontology database. From the seven genes fulfilling this criteria (CIT, DTL, KIF2C, MAPRE1, MSH2, SMC1A and TIMELESS), we choose to focus on DTL because it showed the strongest downregulation upon miR-30a-5p overexpression and its role in cell cycle regulation was well described in the literature (24) (25) (26) (27) (28) (29) . Subsequently, downregulation of the DTL transcript upon miR-30a-5p overexpression was successfully validated by qRT-PCR in our model cell lines, HCT116 (MSI) and SW480 (MSS) (Figure 2A ; Supplementary Figure S3 , available at Carcinogenesis Online), respectively. Importantly, published downstream target genes of DTL, such as CDK1 and CDKN1A, likely key to the described previously DTL-dependent cell cycle regulation (30) (31) (32) , were also among our list of miR-30a-5p-regulated genes and were validated via qRT-PCR (Figure 2A) . The observed changes of DTL and CDKN1A at the transcript level following overexpression of miR-30a-5p were also present at the protein level ( Figure 2B ). In addition, increased p53 protein expression [probably via DTL-dependent stabilization of the p53 protein (33) ] could be shown in the p53-wt HCT116 cells by western blotting (Figure 2B) . Lastly, the only previously shown miR-30a target gene modulated at the transcript level (13), MYBL2, was not found to be altered by miR-30a-5p overexpression in our model system, although its expression was measured well above background according to the array data (data not shown).
DTL is upregulated in primary colorectal cancer tissues
To corroborate the potential importance of DTL in primary colorectal adenocarcinomas, we analyzed the DTL transcript expression in an mRNA microarray data set derived from 379 colorectal adenocarcinomas and 10 normal colon mucosas. The expression of the DTL mRNA accessed by two different probe sets was significantly (P 5 5.3 Â 10 -6 ) increased in colon adenocarcinomas (median log 2 7.9) by about 5-fold compared with normal colon mucosa (median log 2 5.8). Moreover, 364 of the 379 adenocarcinomas (96.04%) showed expression intensities above log 2 6, emphasizing an important role of DTL in colon cancer (Figure 3) . Interestingly, expression was about 2-fold higher in MSI tumors compared with MSS tumors (P 5 3 Â 10 -7 ). We found no association of DTL expression with CRC stage or site (colon versus rectum).
DTL expression correlates with miR-30a-5p expression in primary CRC To evaluate the correlation between DTL and miR-30a-5p expression in primary CRCs, we measured expression of DTL and miR-30a-5p in 10 microdissected samples from fresh frozen tissues (eight colorectal cancer and two normal adjacent colonic mucosa tissues). Expression of DTL and miR-30a-5p exhibited a significant inverse correlation of 0.04 calculated by Pearson correlation, further supporting the miR30a-5p target status of DTL (Supplementary Figure S4 is available at Carcinogenesis Online). Mean values for DTL and miR-30a-5p expression in our series of primary tissue specimen are shown in Supplementary Table SIV, available at Carcinogenesis Online.
DTL is a direct target of miR-30a-5p
To test whether miR-30a-5p directly targets DTL, we performed luciferase reporter assays using 3#UTR sequence fragments of the DTL transcript containing two predicted binding sites for miR-30a-5p ( Figure 4A ). Transient cotransfection of human embryonic kidney 293T cells with miR-30a-5p yielded a highly significant decrease in luciferase reporter activity for both vectors (46 and 81%, respectively) compared with transfection with the empty vector ( Figure 4B ). The binding specificity was further tested by mutating the 3#UTR seed recognition sequence in the reporter vector ( Figure 4B ). Taken together, these results indicate that miR-30a-5p regulates DTL directly via both predicted miR-30a-5p binding sites.
Next, we carried out a 'rescue' experiment by introducing a DTL expression cassette into HCT116 and SW480 cells lacking the miR30a-5p 3#UTR region to additionally confirm that growth inhibition by miR-30a-5p is mediated at least in part through the reduction of DTL expression (Supplementary Figure S5A is available at Carcinogenesis Online). Successful expression of this miR-30a-5p 'insensitive' DTL was monitored at the transcript and protein level ( Figure 5B ; Supplementary Figure S5B is available at Carcinogenesis Online). RTCA analyses revealed that cells expressing the miR-30a-5p insensitive DTL showed a reduced sensitivity toward miR-30a-5p-induced growth inhibition as compared with control cells (Figure 5A ), being in line with our working hypothesis, that DTL is a direct miR-30a-5p target. This rescue effect was also readily visible in standard cell culture (cell culture in a 10 cm tissue culture dishes; data not shown). Furthermore, the expression of a miR-30a-5p insensitive DTL revealed the expected reversion in the cell cycle phase distribution (Supplementary Figure S6 is available at Carcinogenesis Online). Of note, the rescue experiments did not lead to the same growth characteristics as control cells without miR-30a-5p overexpression ( Figure 5A ), suggesting that the observed miR-30a-5p-dependent growth inhibition may also involve additional, yet unknown target genes, which together with DTL impinge on cell growth signaling.
Discussion
Downregulated expression of miR-30a-5p has been reported in a wide range of tumors, among those also human CRC (6, 7, 34) . Here, we performed stable overexpression of miR-30a-5p in two colon cancer cell lines (HCT116, MSI, p53-wt and SW480, MSS, p53-deficient). We found that miR-30a-5p overexpression is able to induce growth inhibition in colon cancer cells, which is accompanied by an induction Fig. 2 . Validation of mRNA microarray data via qRT-PCR and analysis of the candidate genes at the protein level. (A) DTL and CDK1 expressions were decreased and the expression of CDKN1A was increased in p53-wt HCT116 cells following transduction with the pLKO.1-puro-miR-30a-5p vector compared with the control vector. Relative expression levels were normalized to UBC and PPIA mRNA levels. Mean ± SD derived from three independent experiments ( ÃÃ P , 0.01; two-tailed Student's t-test). (B) The DTL protein level was downregulated and p53 and CDKN1A protein levels were upregulated in HCT116 colon cancer cells (MSI, p53-wt) transfected with miR-30a-5p as shown by western immunoblot analyses. Fig. 3 . DTL transcript expression in normal colon mucosa and adenocarcinomas. Colorectal tissue samples from 10 adjacent normal mucosas and 379 primary CRCs were analyzed on U133 plus 2.0 microarrays. DTL was significantly differential expressed between normal mucosa (median log 2 5.8) and adenocarcinomas (median log 2 7.9) (P 5 5.3 Â 10 -6
; two-tailed Student's t-test).
A. Baraniskin et al. of cellular apoptosis and an increase of cells arrested in G 1 phase. Furthermore, making use of a so called 'sponge' against anti-guide strand (herein called antisense-miR-30a-5p), we were able to control for a possible 'off-target' effect by the RISC containing the anti-guide strand derived from our hairpin vector as it was described by Wei et al.
(23) for similar short hairpin RNA vector-based experiments. We confirmed that the observed effect on cell growth is primarily mediated by the RISC containing the guide strand coding for miR-30a-5p.
In order to identify miR-30a-5p target genes, we applied combined mRNA microarray expression profiling to miR-30a-5p overexpressing HCT116 cells with in silico seed site analysis (35, 36) . In this approach, only common genes passing both filters (downregulated in the array experiment und predicted in silico as target for miR30a-5p) are further considered as target candidates, helping to substantially enrich for potential functional candidate genes regulated by miR-30a-5p in the actual test model. A potential down side of measuring gene expression is the inherent inability to monitor translational repression events mediated by miR-30a-5p. However, in the light of recent publications, showing that translational repression plays merely a minor part in target regulation by miRNAs compared with mRNA destabilization (37, 38) , it seems likely that our global gene expression analysis is a valid strategy to detect potential miRNA target genes and that only a minor fraction of target genes are not amenable through this approach. From the 23 target genes identified by this combined approach, we selected DTL for further analyses, not least because its role in cell cycle regulation has previously been shown (24) (25) (26) (27) (28) (29) , thus fitting well with our observation that miR-30a-5p overexpression led to an increase of cells in G 1 phase. In addition, in a large collection of CRC, we identified significant overexpression of DTL in the majority of cases. Likewise, an inverse correlation between DTL and miR-30a-5p expression was observed in primary CRC specimen. In summary, these data support a functional link between miR30a-5p and DTL which is modulating colon cancer growth.
DTL, also known as retinoic acid-regulated nuclear matrix-associated protein or DNA replication factor 2 (CDT2), was first identified to be downregulated during retinoic acid-induced neuronal differentiation of NT2 cell (24) . DTL is located at chromosomal region 1q32.1-32.2 and encodes a putative 730 amino acid nuclear protein that contains six highly conserved WD40-repeat domains (29) . It has been reported that DTL plays an essential role in cell proliferation, cell cycle arrest and metastatic potential in hepatocellular carcinoma, breast cancer, gastric cancer and rhabdomyosarcoma (25) (26) (27) (28) (29) .
Recently, Banks et al. (33) found that DTL induces p53 polyubiquitination through MDM2 and CUL4A/DDB1 complexes. They show that inactivation of DTL causes accumulation of p53 and subsequently raise CDKN1A expression levels, a well-known p53 target gene (33) . In line with these observations, overexpression of miR-30a-5p reduced in our colon cancer model the expression level of the DTL protein and increased both p53 and CDKN1A protein levels. Thus, our data confirm this regulatory circuit in HCT116 cells and add miR30a-5p as an upstream component of the DTL-p53 signaling pathway. Interestingly, Nishitani et al. (31) showed that DTL is furthermore The two putative miR-30a-5p target sequences from DTL were cloned into the 3#UTR of a luciferase reporter gene. Seed site mutagenesis was used to control for binding specificity (positions 795-816 and 1594-1615 of DTL 3#UTR). Luciferase activity was accessed and normalized to b-galactosidase activity.
ÃÃ P , 0.01 compared with the control, two-tailed Student's t-test. Reporter vector data were measured in triplicates for each of the three independent transfection experiments. MiR-30a-5p targets DTL in colon carcinoma able to ubiquitinate the CDKN1A protein. These data suggest that both, a p53-dependent and -independent mode of CDKN1A regulation via DTL are operable in the cell. In line with the data from Banks et al., we observed CDKN1A upregulation at the transcript level upon miR-30a-5p overexpression only in the p53-wt cells (HCT116) but not in the p53-mut cells (SW480). It is well conceivable, based on the data from Nishitani et al., that CDKN1A is regulated at the protein level only in SW480 cells (not analyzed herein) and at the transcript and protein level in HCT116 cells. These data provide a unifying model how miRNA-30a-5p is able to modulate the cell cycle via increased CDKN1A expression irrespective of the p53 mutational status, thus leading to the observed reduced growth rate upon miR30a-5p overexpression in both our p53-wt and p53-mut cell model systems ( Figure 6) .
Apart from the miR-30a-5p-dependent upregulation of CDKN1A, we also confirmed a reduced expression of the CDK1 gene in the p53-wt but not in p53-mut cells. p53 has been described to inhibit transcription of CDK1 (39) . Thus, reduced CDK1 expression levels may also help to control, at least in part, transcription of G 1 /S cyclin genes in our model system (40) .
Recently, Song et al. (28) demonstrated that miR-215, via targeting DTL, is able to suppress cell growth in osteosarcoma and colon cancer cells. These data fit very well into our current view of miRNAs being modest gene expression regulators and that cooperation with multiple binding sites for the same miRNA and/or different miRNAs may help to deepen the suppressive effect on a given target gene (41) . Thus, the downregulation of both miR-215 and miR-30a-5p observed in colon cancer cells may impinge on the same target gene (DTL) resulting in the increase of DTL expression to the critical level necessary to promote tumor growth. It is noteworthy that the model of Song et al. using transient miRNA-215 overexpression in HCT116 cells induced cell cycle arrest at the G 2 phase and not at the G 1 phase as found in our study (28) . Both Song et al. and our study show that miRNA-driven reduction of DTL expression induces CDKN1A expression, a CDK inhibitor, known to inhibit the cell cycle at the late G 1 and during G 2 phase. Thus, it seems plausible, that the discrepancy between the data from Song et al. and our study can be resolved by the possibility that additional genes co-regulated directly or indirectly by miR-215 or miR-30a-5p are tipping the balance to either induce a G 1 or G 2 arrest. Furthermore, our rescue experiment showing only a partial rescue from the growth-inhibitory effect of miR-30a-5p, strongly argues that additional targets are co-modulated by miR-30a-5p, some of them likely influencing directly or indirectly cell cycle and/or apoptosis signaling nodes, responsible for the growth-suppressive effect of miR-30a-5p. This notion is supported by the fact that among the 23 potential miR30a-5p target genes identified in this study, 7 are involved in cell cycle, and within the 343 genes modulated by miR-30a-5p overexpression, 75 are attributed in the GO database 'biological process' to cell cycle. Lastly, in our list of identified miR-30a-5p target genes, TIMELESS was among the genes, which are known to be able to modulate replication and intra-S checkpoints and to be involved in G 2 /M checkpoint control. Downregulation of TIMELESS would in this model reduce replication and thus the fraction of cell in the G 2 phase (42) . A comparative global gene expression coupled with functional studies in both miRNA overexpression models should help to resolve this issue in future experiments.
In summary, our data provide evidence that miR-30a-5p, which is frequently downregulated in colon carcinoma, supports the multi-step process of colorectal cancer development via modulating DTL expression, which in turn alters cell cycle progression. Furthermore, in MSI colon cancer cells, cell cycle control via the miR-30a-5p-dependent DTL regulation includes the p53-CDKN1A signaling pathway. Therefore, both miR-30a-5p and DTL can be regarded as potential targets for colon cancer therapy by either re-expressing miR-30a-5p and/or interfering with DTL function.
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